Medical Device Investing Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
Medical Device Investing Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
Medical Device Investing OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, Olaparib
